ID

19358

Description

Managing Acute Schizophrenia, a Comparison Between Two Atypical Antipsychotics; ODM derived from: https://clinicaltrials.gov/show/NCT00485498

Lien

https://clinicaltrials.gov/show/NCT00485498

Mots-clés

  1. 21/12/2016 21/12/2016 -
Téléchargé le

21 décembre 2016

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Schizophrenia NCT00485498

Eligibility Schizophrenia NCT00485498

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
male or female subjects, aged 18 - 60
Description

Age

Type de données

boolean

Alias
UMLS CUI [1]
C0001779
subjects must meet a clinical diagnosis of schizophrenia, schizophreniform disorder, or schizoaffective disorder according to dsm-iv
Description

Schizophrenia | Schizophreniform Disorders | Schizoaffective Disorder

Type de données

boolean

Alias
UMLS CUI [1]
C0036341
UMLS CUI [2]
C0036358
UMLS CUI [3]
C0036337
subjects' illness must not, in the opinion of the investigator, be caused by substance abuse
Description

Illness caused by Substance Use Disorders

Type de données

boolean

Alias
UMLS CUI [1,1]
C0221423
UMLS CUI [1,2]
C0015127
UMLS CUI [1,3]
C0038586
bprs total score (1 to 7 scale) of greater than or equal to 36 at visit 1
Description

Brief Psychiatric Rating Scale

Type de données

boolean

Alias
UMLS CUI [1]
C0029941
subjects must have a minimum total score of greater than or equal to 14 on the five items of the panss-ec and at least one individual item score of greater than or equal to 4 using the 1-7 scoring system prior to first dose of double-blind medications
Description

Positive and negative syndrome scale

Type de données

boolean

Alias
UMLS CUI [1]
C0451383
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
treatment with antipsychotics or benzodiazepines within 4 hours prior to the first study drug administration
Description

Antipsychotic Agents | Benzodiazepines

Type de données

boolean

Alias
UMLS CUI [1]
C0040615
UMLS CUI [2]
C0005064
treatment with an injectable depot neuroleptic within 1 injection interval prior to study drug administration
Description

Injection of depot antipsychotic agent

Type de données

boolean

Alias
UMLS CUI [1]
C2585377
electroconvulsive therapy (ect) within 1 month (90 days) prior to study entry (visit 1)
Description

Electroconvulsive Therapy

Type de données

boolean

Alias
UMLS CUI [1]
C0013806
treatment with remoxipride within 6 months (180 days) prior to visit 1
Description

Remoxipride

Type de données

boolean

Alias
UMLS CUI [1]
C0073047
documented history of allergic reaction to study medications
Description

Allergic Reaction Investigational New Drugs

Type de données

boolean

Alias
UMLS CUI [1,1]
C1527304
UMLS CUI [1,2]
C0013230

Similar models

Eligibility Schizophrenia NCT00485498

Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
male or female subjects, aged 18 - 60
boolean
C0001779 (UMLS CUI [1])
Schizophrenia | Schizophreniform Disorders | Schizoaffective Disorder
Item
subjects must meet a clinical diagnosis of schizophrenia, schizophreniform disorder, or schizoaffective disorder according to dsm-iv
boolean
C0036341 (UMLS CUI [1])
C0036358 (UMLS CUI [2])
C0036337 (UMLS CUI [3])
Illness caused by Substance Use Disorders
Item
subjects' illness must not, in the opinion of the investigator, be caused by substance abuse
boolean
C0221423 (UMLS CUI [1,1])
C0015127 (UMLS CUI [1,2])
C0038586 (UMLS CUI [1,3])
Brief Psychiatric Rating Scale
Item
bprs total score (1 to 7 scale) of greater than or equal to 36 at visit 1
boolean
C0029941 (UMLS CUI [1])
Positive and negative syndrome scale
Item
subjects must have a minimum total score of greater than or equal to 14 on the five items of the panss-ec and at least one individual item score of greater than or equal to 4 using the 1-7 scoring system prior to first dose of double-blind medications
boolean
C0451383 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Antipsychotic Agents | Benzodiazepines
Item
treatment with antipsychotics or benzodiazepines within 4 hours prior to the first study drug administration
boolean
C0040615 (UMLS CUI [1])
C0005064 (UMLS CUI [2])
Injection of depot antipsychotic agent
Item
treatment with an injectable depot neuroleptic within 1 injection interval prior to study drug administration
boolean
C2585377 (UMLS CUI [1])
Electroconvulsive Therapy
Item
electroconvulsive therapy (ect) within 1 month (90 days) prior to study entry (visit 1)
boolean
C0013806 (UMLS CUI [1])
Remoxipride
Item
treatment with remoxipride within 6 months (180 days) prior to visit 1
boolean
C0073047 (UMLS CUI [1])
Allergic Reaction Investigational New Drugs
Item
documented history of allergic reaction to study medications
boolean
C1527304 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial